Fenofibrate Supplier-Buyer Network — Trade Flow Analysis

Name: Fenofibrate Supplier-Buyer Trade Network Dataset — 168+ Indian Exporters, 19+ Importers, 81+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Fenofibrate supplier network, Fenofibrate buyers, pharmaceutical export India, Fenofibrate trade data

TransData Nexus

Fenofibrate

India Pharmaceutical Trade Intelligence

$73.4M168 Suppliers81 CountriesHS 30049099

ExportsIndia → UNITED STATES43.4%India → BELGIUM8.7%

ImportsUNITED STATES → India$13.3K CANADA → India$3.1K

#1 Buyer: YUSEN LOGISTICS

Who Supplies Fenofibrate? Top Manufacturers & Buyers 2026 — ABBOTT HEALTHCARE PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1ABBOTT HEALTHCARE PRIVATE LIMITED

ABBOTT HEALTHCARE PRIVATE LIMITED is the first-largest Fenofibrate exporter from India, with a market share of 11.7% and a total export value of $8.6M across 50 shipments. Their average shipment value of $172.3K is above the market average of $26.3K, suggesting premium or bulk contract pricing.

ABBOTT HEALTHCARE PRIVATE LIMITED serves 5 named buyers in our database. MYLAN HUNGARY KFT is the dominant customer, accounting for 66.8% of this supplier's tracked business. Top customers include:

• MYLAN HUNGARY KFT — $5.8M across 33 shipments (66.8% of this supplier's total exports)

• MYLAN LABORATORIES SAS — $1.8M across 10 shipments (20.8% of this supplier's total exports)

• DSV AIR & SEA NEDERL — $555.7K across 3 shipments (6.5% of this supplier's total exports)

• ALPHAPHARM PTY LTD — $280.1K across 2 shipments (3.3% of this supplier's total exports)

• ALLOGA (NEDERLAND) B.V. — $231.7K across 1 shipments (2.7% of this supplier's total exports)

Key Insight: ABBOTT HEALTHCARE PRIVATE LIMITED's per-shipment value of $172.3K is 556% above the market average of $26.3K, consistent with large-order contracts or value-added formulations.

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Fenofibrate exporter from India, with a market share of 8.6% and a total export value of $6.3M across 113 shipments. Their average shipment value of $56.1K is above the market average of $26.3K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 93.5% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $5.9M across 106 shipments (93.5% of this supplier's total exports)

• SUN PHARMA CANADA IN — $142.0K across 3 shipments (2.2% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $122.8K across 2 shipments (1.9% of this supplier's total exports)

• M/S. RANBAXY FARMACE — $76.3K across 1 shipments (1.2% of this supplier's total exports)

• M/S. RANBAXY FARMACE — $69.4K across 1 shipments (1.1% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $56.1K is 114% above the market average of $26.3K, consistent with large-order contracts or value-added formulations.

3CIPLA LIMITED

CIPLA LIMITED is the third-largest Fenofibrate exporter from India, with a market share of 7.6% and a total export value of $5.6M across 329 shipments. Their average shipment value of $16.9K is below the market average of $26.3K, reflecting a high-volume, competitive pricing strategy.

CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $2.2M across 130 shipments (39.5% of this supplier's total exports)

• ARROW PHARMACEUTICALS PTY LTD, — $1.9M across 114 shipments (34.7% of this supplier's total exports)

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.1M across 66 shipments (20.0% of this supplier's total exports)

• ARROW PHARMACEUTICALS PTY LTD, — $162.0K across 10 shipments (2.9% of this supplier's total exports)

• ARROW PHARMACEUTICALS PTY LTD, — $161.5K across 10 shipments (2.9% of this supplier's total exports)

Key Insight: CIPLA LIMITED operates with high shipment frequency (329 shipments) at a per-shipment value of $16.9K, indicating a broad distribution network with many smaller, regular orders.

4ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED

ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED is the fourth-largest Fenofibrate exporter from India, with a market share of 4.8% and a total export value of $3.5M across 68 shipments. Their average shipment value of $52.0K is above the market average of $26.3K, suggesting premium or bulk contract pricing.

ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• HANLIM PHARM. CO., LTD — $1.2M across 23 shipments (33.6% of this supplier's total exports)

• HANLIM PHARM CO LIMITED — $992.5K across 19 shipments (28.1% of this supplier's total exports)

• HANLIM PHARM. CO., LTD — $528.1K across 10 shipments (14.9% of this supplier's total exports)

• HANLIM PHARM CO — $415.7K across 8 shipments (11.7% of this supplier's total exports)

• M/S. HANLIM PHARM. C — $412.2K across 8 shipments (11.7% of this supplier's total exports)

Key Insight: ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED's per-shipment value of $52.0K is 98% above the market average of $26.3K, consistent with large-order contracts or value-added formulations.

5AJANTA PHARMA LIMITED

AJANTA PHARMA LIMITED is the fifth-largest Fenofibrate exporter from India, with a market share of 4.2% and a total export value of $3.1M across 105 shipments. Their average shipment value of $29.2K is above the market average of $26.3K, suggesting premium or bulk contract pricing.

AJANTA PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AJANTA PHARMA PHILIPPINES INC — $1.5M across 52 shipments (49.5% of this supplier's total exports)

• XXANTXXPHAXXA UXX IN — $647.6K across 22 shipments (21.2% of this supplier's total exports)

• AJANTA PHARMA USA INC. C/O RXCROSSR — $377.7K across 13 shipments (12.3% of this supplier's total exports)

• AJANTA PHARMA USA INC. C/O RXCROSSR — $272.8K across 9 shipments (8.9% of this supplier's total exports)

• AJANTA PHARMA USA INC. C/O RXCROSSR — $248.1K across 9 shipments (8.1% of this supplier's total exports)

Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $29.2K is 11% above the market average of $26.3K, consistent with large-order contracts or value-added formulations.

6HETERO LABS LIMITED

HETERO LABS LIMITED is the fifth-largest Fenofibrate exporter from India, with a market share of 3.1% and a total export value of $2.3M across 338 shipments. Their average shipment value of $6.8K is below the market average of $26.3K, reflecting a high-volume, competitive pricing strategy.

HETERO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER — $992.9K across 147 shipments (43.4% of this supplier's total exports)

• TO THE ORDER OF — $702.7K across 104 shipments (30.7% of this supplier's total exports)

• M/S — $232.3K across 34 shipments (10.1% of this supplier's total exports)

• CAMBER PHARMACEUTICA — $190.6K across 28 shipments (8.3% of this supplier's total exports)

• TO THE ORDER — $171.7K across 25 shipments (7.5% of this supplier's total exports)

Key Insight: HETERO LABS LIMITED operates with high shipment frequency (338 shipments) at a per-shipment value of $6.8K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Fenofibrate imports from India, with a total trade value of $31.8M across 763 shipments — representing a 43.4% share of all Fenofibrate exports. The average shipment value of $41.7K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Fenofibrate importers in United States: LIFESTAR PHARMA LLC is the largest buyer, accounting for 14.6% ($4.7M) of this market's total imports.

• LIFESTAR PHARMA LLC — $4.7M (14.6% of United States's total)

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $3.2M (10.0% of United States's total)

• AMNEAL PHARMACEUTICALS, LLC (KY) — $2.7M (8.5% of United States's total)

Key Insight: United States's per-shipment average of $41.7K (59% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Fenofibrate imports from India.

Primary Market

Secondary Market

2Belgium

Belgium ranks as the second-largest destination for Fenofibrate imports from India, with a total trade value of $6.4M across 74 shipments — representing a 8.7% share of all Fenofibrate exports. The average shipment value of $86.0K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Fenofibrate importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 97.0% ($6.2M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $6.2M (97.0% of Belgium's total)

Key Insight: Belgium's per-shipment average of $86.0K (228% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Fenofibrate imports from India.

Primary Market

Secondary Market

3Australia

Australia ranks as the third-largest destination for Fenofibrate imports from India, with a total trade value of $6.0M across 14 shipments — representing a 8.2% share of all Fenofibrate exports. The average shipment value of $429.2K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Fenofibrate importers in Australia: ARROW PHARMACEUTICALS PTY LTD, is the largest buyer, accounting for 36.8% ($2.2M) of this market's total imports.

• ARROW PHARMACEUTICALS PTY LTD, — $2.2M (36.8% of Australia's total)

Key Insight: Australia's per-shipment average of $429.2K (1535% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Fenofibrate imports from India.

Primary Market

Secondary Market

4South Korea

South Korea ranks as the fourth-largest destination for Fenofibrate imports from India, with a total trade value of $4.7M across 9 shipments — representing a 6.4% share of all Fenofibrate exports. The average shipment value of $521.8K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Fenofibrate importers in South Korea: HANLIM PHARM. CO., LTD. is the largest buyer, accounting for 25.3% ($1.2M) of this market's total imports.

• HANLIM PHARM. CO., LTD. — $1.2M (25.3% of South Korea's total)

• HANLIM PHARM CO LIMITED — $992.5K (21.1% of South Korea's total)

• HANLIM PHARM. CO., LTD — $962.5K (20.5% of South Korea's total)

Key Insight: South Korea's per-shipment average of $521.8K (1887% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Korea is a key market for Fenofibrate imports from India.

Primary Market

Secondary Market

5France

France ranks as the fifth-largest destination for Fenofibrate imports from India, with a total trade value of $4.7M across 44 shipments — representing a 6.4% share of all Fenofibrate exports. The average shipment value of $105.9K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Fenofibrate importers in France: MYLAN HUNGARY KFT is the largest buyer, accounting for 123.5% ($5.8M) of this market's total imports.

• MYLAN HUNGARY KFT — $5.8M (123.5% of France's total)

• MYLAN LABORATORIES SAS — $3.9M (84.4% of France's total)

Key Insight: France's per-shipment average of $105.9K (303% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Fenofibrate imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fenofibrate.
2.Flow Mapping: 168 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,794 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 81 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,794 Verified Shipments

168 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Fenofibrate

Fenofibrate

Who Supplies Fenofibrate? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Fenofibrate — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Fenofibrate? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Fenofibrate Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ABBOTT HEALTHCARE PRIVATE LIMITED

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

3CIPLA LIMITED

4ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED

5AJANTA PHARMA LIMITED

6HETERO LABS LIMITED

From Indian Factories to Global Pharmacies — How Fenofibrate Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Fenofibrate Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Belgium

3Australia

4South Korea

5France

People Also Ask — Fenofibrate Supplier & Trade Network

Fenofibrate Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology